An update on thyroid disorders in the postpartum period.

Area of Science:

• Endocrinology
• Reproductive Medicine
• Immunology

Background:

• Pregnancy induces immunotolerance, followed by a rebound in the postpartum period.
• Postpartum thyroid dysfunction (PPTD) presents unique diagnostic and management challenges.
• Thyroid disorders during lactation require careful consideration of treatment safety.

Purpose of the Study:

• To review the pathophysiology, diagnosis, and management of postpartum thyroid dysfunction.
• To outline the management of thyroid disorders during lactation.

Main Methods:

• Literature review on postpartum thyroid dysfunction.
• Literature review on management of thyroid disorders during lactation.

Main Results:

• Routine screening for PPTD is not recommended; consider testing high-risk women (e.g., history of thyroid disease, autoimmune conditions) 6-12 weeks postpartum.
• Thyroid stimulating hormone (TSH) testing is advised for postpartum depression or lactation difficulties.
• Differentiate Graves' disease from postpartum thyroiditis; safe medications (levothyroxine, low-dose antithyroid drugs) exist for lactating women, but radioactive iodine is contraindicated.

Conclusions:

• Diagnosing PPTD is challenging due to subtle symptoms.
• A multidisciplinary team approach (PCPs, endocrinologists, obstetricians) is crucial for seamless thyroid care transition.
• Ongoing monitoring is recommended post-PPTD due to high hypothyroidism risk.